Brus R - Search Results

1

Histaminergic activity in a rodent model of Parkinson's disease.

Nowak P, Noras L, Jochem J, Szkilnik R, Brus H, Körossy E, Drab J, Kostrzewa RM, Brus R. Nowak P, et al. Among authors: brus r, brus h. Neurotox Res. 2009 Apr;15(3):246-51. doi: 10.1007/s12640-009-9025-1. Epub 2009 Feb 28. Neurotox Res. 2009. PMID: 19384597

2

Dopamine receptor supersensitivity: an outcome and index of neurotoxicity.

Kostrzewa RM, Kostrzewa JP, Brus R. Kostrzewa RM, et al. Among authors: brus r. Neurotox Res. 2003;5(1-2):111-8. doi: 10.1007/BF03033376. Neurotox Res. 2003. PMID: 12832226

3

Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.

Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP. Brus R, et al. Neurotox Res. 2003;5(5):329-38. doi: 10.1007/BF03033153. Neurotox Res. 2003. PMID: 14715452

4

Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity.

Brus R, Nowak P, Szkilnik R, Mikolajun U, Kostrzewa RM. Brus R, et al. Neurotox Res. 2004;6(4):317-25. doi: 10.1007/BF03033442. Neurotox Res. 2004. PMID: 15545015

5

Dopamine D2 agonist priming in intact and dopamine-lesioned rats.

Kostrzewa RM, Kostrzewa JP, Nowak P, Kostrzewa RA, Brus R. Kostrzewa RM, et al. Among authors: brus r. Neurotox Res. 2004;6(6):457-62. doi: 10.1007/BF03033281. Neurotox Res. 2004. PMID: 15639779

6

Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment.

Kostrzewa RM, Huang NY, Kostrzewa JP, Nowak P, Brus R. Kostrzewa RM, et al. Among authors: brus r. Neurotox Res. 2007 Jan;11(1):41-50. doi: 10.1007/BF03033481. Neurotox Res. 2007. PMID: 17449447 Review.

7

Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.

Nowak P, Bortel A, Dabrowska J, Oswiecimska J, Drosik M, Kwiecinski A, Opara J, Kostrzewa RM, Brus R. Nowak P, et al. Among authors: brus r. Neurotox Res. 2007 Feb;11(2):131-44. doi: 10.1007/BF03033391. Neurotox Res. 2007. PMID: 17449455

8

Ontogenetic noradrenergic lesion alters histaminergic activity in adult rats.

Nowak P, Jochem J, Zwirska-Korczala K, Josko J, Noras L, Kostrzewa RM, Brus R. Nowak P, et al. Among authors: brus r. Neurotox Res. 2008 Apr;13(2):79-83. doi: 10.1007/BF03033559. Neurotox Res. 2008. PMID: 18515210

9

Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.

Nowak P, Bortel A, Dabrowska J, Biedka I, Slomian G, Roczniak W, Kostrzewa RM, Brus R. Nowak P, et al. Among authors: brus r. Neurotox Res. 2008 May-Jun;13(3-4):231-40. doi: 10.1007/BF03033506. Neurotox Res. 2008. PMID: 18522902

10

Neonatal DSP-4 treatment modifies GABAergic neurotransmission in the prefrontal cortex of adult rats.

Bortel A, Nowak P, Brus R. Bortel A, et al. Among authors: brus r. Neurotox Res. 2008 May-Jun;13(3-4):247-52. doi: 10.1007/BF03033508. Neurotox Res. 2008. PMID: 18522904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters